158 related articles for article (PubMed ID: 12556407)
1. Biodegradable intrascleral implant for sustained intraocular delivery of betamethasone phosphate.
Okabe J; Kimura H; Kunou N; Okabe K; Kato A; Ogura Y
Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):740-4. PubMed ID: 12556407
[TBL] [Abstract][Full Text] [Related]
2. Intraocular tissue distribution of betamethasone after intrascleral administration using a non-biodegradable sustained drug delivery device.
Okabe K; Kimura H; Okabe J; Kato A; Kunou N; Ogura Y
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2702-7. PubMed ID: 12766076
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of drug delivery to the posterior pole of the rabbit eye with an episcleral implant.
Kato A; Kimura H; Okabe K; Okabe J; Kunou N; Ogura Y
Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):238-44. PubMed ID: 14691179
[TBL] [Abstract][Full Text] [Related]
4. Effect of benzalkonium chloride on transscleral drug delivery.
Okabe K; Kimura H; Okabe J; Kato A; Shimizu H; Ueda T; Shimada S; Ogura Y
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):703-8. PubMed ID: 15671302
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable scleral implant for controlled intraocular delivery of betamethasone phosphate.
Kunou N; Ogura Y; Honda Y; Hyon SH; Ikada Y
J Biomed Mater Res; 2000 Sep; 51(4):635-41. PubMed ID: 10880111
[TBL] [Abstract][Full Text] [Related]
6. Ocular tissue distribution of betamethasone after anterior-episcleral, posterior-episcleral, and anterior-intrascleral placement of nonbiodegradable implants.
Okabe K; Kimura H; Okabe J; Ogura Y
Retina; 2007; 27(6):770-7. PubMed ID: 17621189
[TBL] [Abstract][Full Text] [Related]
7. A novel design of one-side coated biodegradable intrascleral implant for the sustained release of triamcinolone acetonide.
Kim YM; Lim JO; Kim HK; Kim SY; Shin JP
Eur J Pharm Biopharm; 2008 Sep; 70(1):179-86. PubMed ID: 18667297
[TBL] [Abstract][Full Text] [Related]
8. Scleral plug of biodegradable polymers containing tacrolimus (FK506) for experimental uveitis.
Sakurai E; Nozaki M; Okabe K; Kunou N; Kimura H; Ogura Y
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4845-52. PubMed ID: 14578407
[TBL] [Abstract][Full Text] [Related]
9. Biodegradable intrascleral implant of triamcinolone acetonide in experimental uveitis.
Shin JP; Park YC; Oh JH; Lee JW; Kim YM; Lim JO; Kim SY
J Ocul Pharmacol Ther; 2009 Jun; 25(3):201-8. PubMed ID: 19456254
[TBL] [Abstract][Full Text] [Related]
10. Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging.
Kim H; Robinson MR; Lizak MJ; Tansey G; Lutz RJ; Yuan P; Wang NS; Csaky KG
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2722-31. PubMed ID: 15277497
[TBL] [Abstract][Full Text] [Related]
11. Preparation and Evaluation of Biodegradable Scleral Plug Containing Curcumin in Rabbit Eye.
Zhang J; Sun H; Zhou N; Zhang B; Ma J
Curr Eye Res; 2017 Dec; 42(12):1597-1603. PubMed ID: 29111828
[TBL] [Abstract][Full Text] [Related]
12. Biodegradable scleral implant for intravitreal controlled release of ganciclovir.
Yasukawa T; Kimura H; Kunou N; Miyamoto H; Honda Y; Ogura Y; Ikada Y
Graefes Arch Clin Exp Ophthalmol; 2000 Feb; 238(2):186-90. PubMed ID: 10766290
[TBL] [Abstract][Full Text] [Related]
13. Laser-induced intrachoroidal dexamethasone drug delivery system to posterior eye segment.
Murata M; Sanbe A; Lee JW; Nishigori H
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8317-24. PubMed ID: 24265021
[TBL] [Abstract][Full Text] [Related]
14. Development of biodegradable controlled release scleral systems of triamcinolone acetonide.
Blatsios G; Tzimas AS; Mattheolabakis G; Panagi Z; Avgoustakis K; Gartaganis SP
Curr Eye Res; 2010 Oct; 35(10):916-24. PubMed ID: 20858113
[TBL] [Abstract][Full Text] [Related]
15. Ocular pharmacokinetics of fluocinolone acetonide following Iluvien implantation in the vitreous humor of rabbits.
Kane FE; Green KE
J Ocul Pharmacol Ther; 2015 Feb; 31(1):11-6. PubMed ID: 25562126
[TBL] [Abstract][Full Text] [Related]
16. Safety and pharmacokinetics of an intravitreal biodegradable implant of dexamethasone acetate in rabbit eyes.
Fialho SL; Rêgo MB; Siqueira RC; Jorge R; Haddad A; Rodrigues AL; Maia-Filho A; Silva-Cunha A
Curr Eye Res; 2006 Jun; 31(6):525-34. PubMed ID: 16769612
[TBL] [Abstract][Full Text] [Related]
17. Toxicity and in vivo release profile of sirolimus from implants into the vitreous of rabbits' eyes.
De Paiva MRB; Lage NA; Guerra MCA; Mol MPG; Ribeiro MCS; Fulgêncio GO; Gomes DA; Da Costa César I; Fialho SL; Silva-Cunha A
Doc Ophthalmol; 2019 Feb; 138(1):3-19. PubMed ID: 30456454
[TBL] [Abstract][Full Text] [Related]
18. In vivo release and retinal toxicity of cyclosporine-loaded intravitreal device.
de Almeida FP; Saliba JB; Ribeiro JA; Siqueira RC; Fialho SL; Silva-Cunha A; Jorge R; Messias A
Doc Ophthalmol; 2015 Dec; 131(3):207-14. PubMed ID: 26576763
[TBL] [Abstract][Full Text] [Related]
19. Assessment of subconjunctival and intrascleral drug delivery to the posterior segment using dynamic contrast-enhanced magnetic resonance imaging.
Kim SH; Galbán CJ; Lutz RJ; Dedrick RL; Csaky KG; Lizak MJ; Wang NS; Tansey G; Robinson MR
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):808-14. PubMed ID: 17251481
[TBL] [Abstract][Full Text] [Related]
20. Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device.
Jaffe GJ; Yang CH; Guo H; Denny JP; Lima C; Ashton P
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3569-75. PubMed ID: 11006254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]